[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370185-105":59,"doc-detail-370185-en":127},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":120,"head_meta":122,"extra_data":124,"updated_unix":126},105,"en","enhanced-targeted-treatment-of-cervical-cancer-using-nanoparticle-based-doxycycline-delivery-system","Enhanced targeted treatment of cervical cancer using nanoparticle-based doxycycline delivery system","","Study presents a nanoparticle-based doxycycline delivery system engineered for cervical cancer targeting via the CD44 receptor. Molecular docking shows strong HA–CD44 binding (−7.2 kJ/mol). HA–chitosan nanoparticles are characterized by 284.6 nm size, 16.9 mV zeta potential, and 0.314 polydispersity; SEM indicates smooth morphology. DOX encapsulation reaches 89.32%, with sustained release and 67.45% drug release in acidic pH (5.5) over 72 h. Cytotoxicity reduces HeLa viability to 22% at 72 h versus 67% in HEK cells. Stability persists for three months, migration declines 45%, and RT-PCR shows 53% TNF-α downregulation, supporting inhibition of tumor-promoting inflammatory pathways.",{"@graph":69,"@context":119},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/enhanced-targeted-treatment-of-cervical-cancer-using-nanoparticle-based-doxycycline-delivery-system/370185/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/enhanced-targeted-treatment-of-cervical-cancer-using-nanoparticle-based-doxycycline-delivery-system/370185.png","ImageObject",300,407,{"name":92,"@type":93},"Patrick","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115],{"name":110,"@type":111,"acceptedAnswer":112},"How effective is the treatment in vitro and how is release behavior described?","Question",{"text":113,"@type":114},"The DOX-loaded nanoparticles show sustained release with 67.45% released over 72 h under acidic conditions (pH 5.5). Cytotoxicity reduces HeLa cell viability to 22% at 72 h while normal HEK cells remain higher (67%).","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What additional biological effects suggest suppression of tumor-related mechanisms?",{"text":118,"@type":114},"Stability tests confirm maintained nanoparticle integrity over three months; cell migration is reduced by 45%, and RT-PCR shows a 53% downregulation of TNF-α, indicating inhibition of inflammatory pathways.","https://schema.org",{"og:url":83,"og:type":121,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":123,"canonical":83},"index,follow",{"doc_id":125,"site_id":62},370185,1790239896,{"code":4,"msg":5,"data":128},{"doc_id":125,"user_id":129,"nickname":92,"user_avatar":130,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":131,"file_id":132,"file_url":133,"file_type":134,"file_size":135,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":136,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":137,"faqs":138,"seo_title":139,"seo_description":67,"update_tm":140,"read_time":31,"preview_page_count":19,"preview_urls":141},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nEnhanced targeted treatment of cervical cancer using nanoparticlebased doxycycline delivery system  \nSadia Anjum1, Ayesha Akhtar2, Saleh M. Aldaqal3, Maisa S. Abduh4, Hammad Ahmad5, Riaz Mustafa6, Faiza Naseer7􀀍, Maryam Sadia2 & Tahir Ahmad2􀀍  \nThis study investigates a nanoparticle-based doxycycline (DOX) delivery system targeting cervical cancer cells via the CD44 receptor. Molecular docking revealed a strong binding affinity between hyaluronic acid (HA) and CD44 (binding energy: -7.2 kJ/mol) . Characterization of the HA-Chitosan nanoparticles showed a particle size of 284.6 nm, a zeta potential of 16.9 mV, and a polydispersity index of 0.314, with SEM confirming smooth surface morphology. The encapsulation efficiency of DOX-loaded nanoparticles was 89.32%, exhibiting a sustained release profile, with 67.45% released over 72 h in acidic conditions (pH 5.5). Cytotoxicity assays demonstrated a significant reduction in HeLa cell viability to 22% at 72 h, compared to 67% in normal HEK cells. Stability tests confirmed the maintenance of nanoparticle integrity and a consistent drug release profile over three months. Cell migration was reduced by 45%, and RT-PCR analysis revealed a 53% downregulation ofTNF-α expression, suggesting effective targeting of inflammatory pathways. These results underscore the potential of HA-Chitosan-based DOX nanoparticles in improving cervical cancer treatment through enhanced targeted delivery and inhibition of tumor-promoting mechanisms.  \nKeywords Doxycycline, Cervical Cancer, Novel Drug Delivery System, Sustained release, Targeted therapy, Immunotherapy  \nCervical cancer (CCa), a prevalent form of cancer among women worldwide, ranks as the third most common. Its impact is particularly devastating in Pakistan, where it claims the lives of over 7000 women annually1. Presently, around 85% of deaths are reported to occur in lower and middle socioeconomic countries. This makes it the principal root of disaese-related fatalities among females in the developing world. Mostly CCa is either squamous cell carcinoma or adenocarcinoma2. The primary treatment approaches including chemotherapy and radiotherapy are used as therapeutic modalities for metastatic and recurrent CCa. A three-drug regimen consisting of carboplatin, paclitaxel, and bevacizumab has emerged as a new standard of care. However, despite their improved outcomes, bevacizumab may not be the most cost-effective therapy.  \nAdditionally, this regimen has a toxicity profile that limits its application in older women or in those with comorbidities such as hypertension or renal disease3. While these conventional options have shown promise in improving the prognosis of CCa, but sometime their severe adverse outcomes are challenging for patients to tolerate. In recent years, nanotechnology has significantly advanced, discovering unique physical, chemical, and biological properties of nanoscale materials. Nano-oncology focuses on utilizing nanobiotechnology in cancer treatment. The drug delivery systems have shown immense potential in enhancing drug bioavailability solubility, altering drug distribution, combating drug resistance, and reducing nonspecific toxicity. Most importantly, it can minimize the side effects of chemotherapy and increase their survival time by improving sufferer’s quality of life4. Doxycycline (DOX), a tetracycline antibiotic, was repurposed as an anticancer drug. It inhibits the synthesis of bacterial protein after it binds to the active aminoacyl-tRNAs at the A-site of the 30 S subunit of bacterial ribosomes. As a result, DOX can unintentionally inhibit mitochondrial biogenesis, leading to its repurposing to be used therapeutically in oncology for targeting cancer cells. DOX offers excellent oral bioavailability and  \n1Department of Biology, University of Hail, Hail, Saudi Arabia. 2Industrial Biotechnology, Atta-ur-Rahman School of Applied Bioscienc","cbCaiin9a35wQA0U","https://ap.wps.com/l/cbCaiin9a35wQA0U","pdf",4326675,"English","# Enhanced targeted treatment of cervical cancer using nanoparticle-based doxycycline delivery system\n## Nanoparticle design and targeting strategy\n## Molecular docking and binding affinity\n## Nanoparticle characterization\n## Drug encapsulation and sustained release\n## Cytotoxicity and cell viability results\n## Stability, migration, and inflammatory pathway effects\n## Clinical context and limitations of conventional therapy","[{\"question\":\"How effective is the treatment in vitro and how is release behavior described?\",\"answer\":\"The DOX-loaded nanoparticles show sustained release with 67.45% released over 72 h under acidic conditions (pH 5.5). Cytotoxicity reduces HeLa cell viability to 22% at 72 h while normal HEK cells remain higher (67%).\"},{\"question\":\"What additional biological effects suggest suppression of tumor-related mechanisms?\",\"answer\":\"Stability tests confirm maintained nanoparticle integrity over three months; cell migration is reduced by 45%, and RT-PCR shows a 53% downregulation of TNF-α, indicating inhibition of inflammatory pathways.\"}]","Enhanced targeted treatment of cervical cancer using nanoparticle-based doxycycline delivery system | PDF",1790187210,[142,146,150,154],{"page_no":8,"url":143,"width":144,"height":145},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2f1039ce46219a83efe1c10627811b1c.webp",983,1291,{"page_no":14,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a10fe7179651d030ea3b837ee43b3aed.webp",982,1290,{"page_no":81,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e0df7ba8ace64a176495139327f42de2.webp",981,1289,{"page_no":19,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a64be663c805992535140c1565006bcc.webp",980,1287]